Bilateral Laryngeal Paralysis Reinnervation

Bilateral laryngeal reinnervation induces a rise in laryngeal resistance and speech alteration. The aim of this study is to propose laryngeal reinnervation by a phrenic nerve root to patients with bilateral laryngeal paralysis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Vocal Cord Paralysis Cranial Nerve Diseases Laryngeal Diseases Nervous System Diseases Neurologic Manifestations Otorhinolaryngologic Diseases Paralysis Pathological Conditions, Signs and Symptoms Respiratory Tract Diseases Signs and Symptoms Vagus Nerve Diseases

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Rouen University Hospital

Rouen, 76031, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Bilateral laryngeal paralysis without any amelioration for six months

Exclusion criteria

Laryngeal paralysis more than 3 years
Arycricoideus ankylostosis
Pacemaker
Pregnancy

Treatment and study plan

surgical reinnervation

Procedure

laryngeal reinnervation with a phrenic nerve root

Primary outcomes

LARYNGEAL REINNERVATION

Time frame: 6 months

Sponsors and collaborators

Lead sponsor

University Hospital, Rouen

Other

Registry information

Official study title

Bilateral Laryngeal Paralysis Reinnervation. Speech and Ventilatory Results Analysis

Important dates

Study start: 2004
Primary completion: 2011
Study completion: 2011
First posted: Sep 21, 2005
Registry last updated: Jun 18, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed